Expression of EMAP II in the developing and adult mouse

Apoptosis

Volumn 5, Issue 2, 2000, Pages 141-151

  Knies, Ulrike E ^a,b   Kröger, Susanne ^a   Clauss, Matthias ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Brain; EMAP II; Immunosurveillance; Monocytes; tRNA multi synthetase complex

Indexed keywords

CHEMOATTRACTANT; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; EMBRYO DEVELOPMENT; GRANULOCYTE; IMMUNOSURVEILLANCE; IN SITU HYBRIDIZATION; IN VITRO STUDY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; THYMUS;

ANIMALS; AORTA; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BRAIN; CATTLE; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; CYTOKINES; EMBRYO; ENDOTHELIUM, VASCULAR; GROWTH INHIBITORS; HUMANS; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; KIDNEY; MALE; MICE; NEOPLASM PROTEINS; PROTEIN PRECURSORS; RNA, MESSENGER; RNA-BINDING PROTEINS; TESTIS; THYMUS GLAND;

MAMMALIA;

EID: 0343673836     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009632712876     Document Type: Article

References (23)

1. Kao J, Ryan J, Brett G, et al. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J Biol Chem 1992; 267: 20239-20247.
2. Kao J, Houck K, Fan Y, et al. Characterization of a novel tumor-derived cytokine: Endothelial-Monocyte Activating Polypeptide II. J Biol Chem 1994; 269: 25106-25119.
3. Quevillon S, Agou F, Robinson JC, Mirande M. The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. J Biol Chem 1997; 272: 32573-32579.
4. Park SG, Jung KH, Lee JS, et al. Precursor of pro-apoptotic cytokine modulates aminoacylation activity of tRNA synthetase. J Biol Chem 1999; 274: 16673-16676.
5. Knies UE, Behrensdorf HA, Mitchell C, et al. Regulation of endothelial monocyte-activating polypeptide II-release by apoptosis. Proc Natl Acad Sci USA 1998; 95: 12322-12327.
6. Schwartz SM. Selection and characterization of bovine aortic endothelial cells. In Vitro 1978; 14: 966-980.
7. Clauss M, Weich HA, Breier G, et al. The vascular endothelial growth factor receptor flt-1 mediates biological activities: Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996; 271: 17629-17634.
8. +RNA from cells in monolayer. Endocrinol 1990; 127: 2038-2040.
9. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth-factor during embryonic angiogenesis and endothelial-cell differentiation. Development 1992; 114: 521-532.
10. Gavrieli Y, Sherman Y, Ben-Sasson S. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
11. Rösl F. A simple and rapid method for detection of apoptosis in human cells. Nucl Acid Res 1992; 20: 5243-5247.
12. Ge SJ, Yao XL, Yang ZX, Zhu ZP. An Arabidopsis embryonic lethal mutant with reduced expression of alanyl-tRNA synthetase gene. Cell Res 1998; 8: 119-134.
13. Cerini C, Semeriva M, Gratecos D. Evolution of the aminoacyl-tRNA synthetase family and the organization of the Drosophila glutamyl-prolyl-tRNA synthetase gene. Intron/exon structure of the gene, control of expression of the two mRNAs, selective advantage of the multienzyme complex. Eur J Biochem 1997; 244: 176-185.
14. Zhang JZ, Somerville CR. Suspensor-derived polyembryony caused by altered expression of valyl-tRNA synthetase in the twn2 mutant of Arabidopsis. Proc Natl Acad Sci USA 1997; 94: 7349-7355.
15. Schwarz M, Lee M, Zhang FR, et al. EMAP II: A modulator of neovascularization in the developing lung. Am J Physiol 1999; 20: L365-L375.
16. Schwarz MA, Kandel J, Brett J, et al. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J Exp Med 1999; 190: 341-353.
17. Blaschke AJ, Staley K, Chun J. Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. Development 1996; 122: 1165-1174.
18. Schluesener HJ, Seid K, Zhao Y, Meyermann R. Localization of endothelial- monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: Expression by monocytes and activated microglial cells. Glia 1997; 20: 365-372.
19. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth-factor is apotential tumor angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-848.
20. Perry VH, Crocker PR, Gordon S. The blood-brain-barrier regulates the expression of a macrophage sialic acid-binding receptor on microglia. J Cell Sci 1992; 101: 201-207.
21. Ashwell K. Microglia and cell death in the developing mouse cerebellum. Brain Research Develop Brain Res 1990; 55: 219-230.
22. Moujahid A, Navascues J, Marinteva JL, Cuadros MA. Macrophages during avian optic nerve development -relationship to cell death and differentiation into microglia. Anat & Embryol 1996; 193: 131-144.
23. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia -intrinsic immune effector cell of the brain [Review]. Brain Res Rev 20: 209-287.